Article summary
The Financial Conduct Authority (FCA) has published the findings from the post-implementation review (PIR) of its rules which aim to improve access to travel insurance for consumers with more serious pre-existing medical conditions. Overall, the FCA considers that its signposting intervention has had a positive but lower than expected impact on the market. The FCA estimates that the intervention resulted in an additional 21,000 policy sales. It will consult later in 2024 on updating the £100 medical condition premium trigger point for signposting. The PIR includes a table of action points for firms to consider.
To continue reading this news article, as well as thousands of others like it, sign in with LexisNexis or register for a free trial